Dyne Therapeutics (DYN) S-3ASR Automatic shelf registration

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated March 5, 2024 relating to the financial statements of Dyne Therapeutics, Inc., appearing in the Annual Report on Form 10-K of Dyne Therapeutics, Inc. for the year ended December 31, 2023. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ Deloitte & Touche LLP

Boston, Massachusetts

March 5, 2024